The largest database of trusted experimental protocols

10 protocols using rpmi 1640

1

Isolation and Culture of Murine Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells, HEK293T cells, RAW264.7 cells, and MEFs were maintained in DMEM (nacalai tesque) with 10% fetal bovine serum (FBS), 1% Penicillin/Streptomycin (nacalai tesque), and 100 µM 2-Mercaptoethanol (nacalai tesque). Mycoplasma contamination was routinely tested and found negative.
For the preparation of bone marrow-derived macrophages (BMDMs), bone marrow cells were cultured in RPMI-1640 (nacalai tesque) with 10% FBS, 1% Penicillin/Streptomycin, 100 μM 2-mercaptoethanol, and 20 ng/ml of macrophage colony-stimulating factor (M-CSF) (BioLegend) for 6 days.
For the preparation of thioglycolate-elicited peritoneal exudate cells (PECs), mice were intraperitoneally injected with 2 ml of 4% (w/v) Brewer’s thioglycollate medium. 3.5 days after the injection, peritoneal macrophages were collected and cultured in RPMI-1640 with 10% FBS, 1% Penicillin/Streptomycin, and 100 μM 2-mercaptoethanol.
+ Open protocol
+ Expand
2

Transwell Assay for CLL Cell Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMC) were isolated using a Ficoll density gradient centrifugation; only samples containing more than 70% CLL cells in PBMC were chosen for the assay. Transmigration of CLL cells was assessed using polycarbonate Transwell inserts with 5-μm pore size (Corning Costar). Briefly, the cells at 1 × 10exp 6/mL were applied to the upper chamber in RPMI-1640 containing 1% bovine serum albumin (BSA) in the presence or absence of CXCL11 (BioLegend). Filters were transferred into the lower wells containing RPMI-1640 with 1% BSA in the presence or absence of CXCL12 (BioLegend). After 3 hours at 37°C in 5% CO2, cells that migrated into the lower chambers were counted and analysed for CXCR3 and CXCR4 expression on BD FACSCanto II.
+ Open protocol
+ Expand
3

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-mouse phosphor-STAT3 (EP2147Y, Abcam), phosphor-NF-κB (pp65) (sc-52401, Santa), phosphor-JNK (pJNK)(9H8), phosphor-ERK (pERK)(197G2), STAT3 (124H6, Cell Signaling), NF-κBp65 (sc8008, Santa), JNK (SC), ERK(137F5), and β-actin (sc-47778, Santa) were purchased. FITC-, PE-, APC- APC/cy7-, PerCP/Cy5.5-, or PE/cy7-conjugated anti-mouse CD4 (RM4-5, Biolegend), CD8 (ZUT270.5, Biolegend), CD45.1 (30-F11, Biolegend), MHCII (I-A/I-E, M5/114.115.2, Biolegend), CD11c (MCA1441GA, Biolegend), CD11b (M1/70, eBioscience), F4/80 (BM8, Biolegend), CD206 (CO68C2), Gr-1(RB6-8C5, eBioscience), IL-10 (JES5-16E3, eBioscience), Foxp3 (MF23, eBioscience), IL-22 (140301, R&D system), IFNγ (XMG1.2, Biolegend), RORγt (AFKJS-9, eBioscience), IL-17A (eBio17B7, eBioscience), and CD3ζ (H146-968, Abcam) antibodies were purchased. Anti- REG3γ (PA517, Thermo) and anti-MUC2 (H300, Santa) were also purchased. FITC-, PE-, APC- APC/cy7-, PerCP/Cy5.5-, or PE/cy7-conjugated isotypic controls were from Biolegend. RPMI1640, DMEM, fetal bovine serum (FBS), and antibiotics were obtained from HyClone. Alexa fluor 488-conjugated goat anti-rabbit IgGH&L and Alexa fluor 594-conjugated goat anti-rabbit IgGH&L (Abcam) were also purchased. 7-AAD was from Abcam.
Lactobacillus reuteri (ATCC PTA 4659) was a gift of BioGaaia, Sweden.
+ Open protocol
+ Expand
4

Multimodal Imaging Probe Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
ZHO was purchased from Bachem UK Ltd. ICG, IR 806, IR 140, RhB, ZnCl2, methanol were purchased from Sigma-Aldrich Inc. BSA was purchased from Solarbio Biotechnology Co. Ltd. MCF-7 cells (catalog number SCSP-669S), 4T1 cells (catalog number SCSP-5056), CT26 cells (catalog number TCM37) and Hela cells (catalog number SCSP-504) were provided by the National Collection of Authenticated Cell Cultures. Dulbecco’s Modified Eagle’s Medium (DMEM), Roswell Park Memorial Institute 1640 (RPMI 1640), heat-inactivated fetal bovine serum (FBS), Dulbecco’s phosphate-buffered saline (PBS), trypsin-EDTA, and penicillin-streptomycin were purchased from BioLegend Co. Other materials were purchased from Beijing Chemical Co. Ltd. unless otherwise noted.
+ Open protocol
+ Expand
5

Neutrophil Migration Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophil migration was assessed using 24-well microchambers and polycarbonate filters (5 μm pore size) (Corning, NY, USA) as described previously40 (link),64 (link). In brief, CD45+ CD11b+ Ly6G+ neutrophils sorted from mouse bone marrow cells were placed in the upper wells (1 × 105 cells/well) of Transwell chambers, and 600 µL of RPMI 1640 medium with or without 100 ng/ml CXCL2 (BioLegend) were added to the lower wells. For migration assays, cells were incubated for 60 min at 37 °C. After the incubation, cells that migrated to the bottom part of the membrane and the lower wells was stained with Hoechst 33,342. The numbers of cells per field were counted in 10 randomly selected visual fields under a microscope (BZ-X810, Keyence, Osaka, Japan), and the mean estimate for individual samples was calculated.
+ Open protocol
+ Expand
6

Expansion of EBV-specific T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained from two EBV-seropositive healthy donors with informed consent under the approval of the Ethical Committee for Epidemiology of Hiroshima University. PBMCs were isolated from buffy coats with density centrifugation using lymphocyte separation medium 1077 (Takara Bio, Shiga, Japan). FACS-sorted CD4+ T cells or CD8+ T cells were plated at 1 × 105 cells per well in a U-bottom 96-well plate and co-cultured with autologous LCL irradiated at 30 Gy starting at 40:1 responder to stimulator ratio in RPMI-1640 supplemented with 10% FCS, 1% Penicillin-streptomycin, and 10 ng/mL human recombinant IL-7 (BioLegend, San Diego, CA, USA). An amount of 10 ng/mL IL-2 was added from day 2 of co-culture. Cells were then re-stimulated with irradiated autologous LCL at a ratio of 1:1 responder to stimulator weekly for a total of 5 stimulation rounds. Thereafter, T cells were expanded in T25 culture flasks on a weekly basis counting, and fed/split as necessary to give a final density of 1–2 × 106 T cells/cm2. All cell counts were given as viable cells via trypan blue exclusion of dead cells.
+ Open protocol
+ Expand
7

Isolation and Activation of Cardiac Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain CD4+ T lymphocytes and antigen-presenting cells (APCs), single-cell suspensions of splenocytes were sorted using BD FACSAria II (BD Biosciences, San Jose, CA, USA). CD4+ T cells and APCs were co-cultured in a 10:1 ratio. CD4+ T cells were activated with anti-CD3/CD28 beads (ThermoFisher, USA) or 10 ng/mL of α-MyHC (Caslo), and the conditioned medium was collected on Day 3 for further experiments. Experiments were performed on primary cardiac microvascular endothelial cells (cMVECs) isolated from hearts of 4-week-old Tnf+/+ and Tnf−/− mice as described previously.19 (link) cMVECs were cultured in RPMI 1640 supplemented with 10% foetal bovine serum (FBS) and 2 ng/mL recombinant mouse epidermal growth factor (BioLegend, USA). cMVECs were activated with recombinant mouse TNF-α (5 ng/mL, BioLegend) or conditional medium. A detailed description is provided in the Supplemental Methods section.
+ Open protocol
+ Expand
8

Isolation and Visualization of Human T and NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human healthy donor peripheral blood mononuclear cells (PBMCs) were isolated using Lymphocyte Separation Solution (Nacalai tesque, Kyoto, Japan). Human T cells and NK cells were enriched from PBMCs by cell depletion of B cells and monocytes using anti-CD19, and anti-CD14 conjugated magnetic beads with Magnisort technology (ThermoFisher). To facilitate visualization, purified T cells were stained with 2 µM Calcein-AM (Nacalai tesque) in PBS for 30 min at 37 °C followed by co-culture. Isolated cells were maintained in a T cell medium; RPMI1640 supplemented with 10% FBS, 100 U/mL human IL-2 and 10 ng/mL human IL-7 (both from Biolegend, CA, USA).
+ Open protocol
+ Expand
9

Craniotomy-associated Leukocyte Immunosuppression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of craniotomy-associated leukocyte populations to inhibit polyclonal T cell activation was performed as previously described (20 ). Briefly, leukocyte populations were isolated from the brain, galea, and bone flap by FACS at days 3 and 7 post-infection using the markers for each cell population described in the Flow Cytometry section. CD4+ T cells were isolated from the spleens of naïve mice using a CD4+ T cell isolation kit (Miltenyi Biotec, Auburn, CA) and immediately labeled with eFluor 670 cell proliferation dye (eBioscience), according to the manufacturer’s instructions. Labeled CD4+ T cells were plated at 105 cells/well in a 96-well round-bottom plate in RPMI-1640 supplemented with 10% FBS and 100 ng/mL IL-2 (BioLegend). FACS-purified leukocytes were added at 1:1 ratios to CD4+ T cells that were subjected to polyclonal stimulation with CD3/CD28 Dynabeads (Life Technologies), since TCR immunodominant epitopes for S. aureus are not defined. Cells were incubated for 72 h, whereupon the extent of T cell proliferation was determined by flow cytometry using a BD LSR II (RRID:SCR_002159).
+ Open protocol
+ Expand
10

Single-Cell Isolation from Solid Tumors and Spleens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor tissue was digested in the RPMI 1640 medium (Gibco) containing DNAse (60 µg/ml), hyaluronidase (0.2 µl/ml), Collagenase IA and IV (0.2 mg/ml each) for 30 min at 37 °C. Required enzymes were obtained from Sigma. Cell solutions were subsequently washed with RPMI and filtered using a 40 -µm cell strainer to obtain single-cell preparations.
Splenocytes were released from spleens by passing through a 40 -µm cell strainer and washed with RPMI 1640 (Gibco). Erythrocytes were lysed by adding 1x EBC lysis buffer (BioLegend) for 5 min at 4 °C, and cells were subsequently washed with RPMI 1640. Cells were resuspended in the RPMI 1640 medium supplemented with 2% FCS, 100 U/mL streptomycin, 100 mg/mL penicillin, 1% MEM with nonessential amino acids (×100 solution, Gibco) ß-mercaptoethanol (50 µM, Sigma), and sodium pyruvate (1 mM, Gibco), and kept at 37 °C and 5% CO2 overnight during peptide stimulation.
Erythrocytes were removed from blood samples by adding ×1 EBC lysis buffer (BioLegend) and incubated for 3 min at 4 °C. Cells were subsequently washed with RPMI 1640 (Gibco).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!